Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Advisors Recommend Ellence For Breast Cancer Treatment BRIDGEWATER, NJ -- June 8, 1999 -- The United States Food and Drug Administration’s oncologic drugs advisory committee has voted to recommend that Pharmacia & Upjohn’s anti-cancer agent Ellence(TM) (epirubicin hydrochloride injection) be approved as a component of adjuvant therapy in patients with evidence of axillary nodal tumour involvement (cancer that has spread to the lymph nodes under the arm) following resection of primary breast cancer. Adjuvant therapy, a mainstay of treatment for early breast cancer, is drug therapy following surgery to destroy any remaining cancer cells. Ellence is being considered for approval based on studies that suggest its use as a component of adjuvant chemotherapy improves overall survival and reduces the risk of cancer recurrence in women with early breast cancer compared to CMF (cyclophosphamide, methotrexate, fluorouracil), a current standard therapy As the anthracycline of choice for the past 15 years, Ellence (marketed as Farmorubicin(R) outside the U.S.) is currently used in more than 80 countries to treat a variety of cancers, including breast cancer. As with other chemotherapies, side effects associated with Ellence are generally predictable and manageable and include hair loss, nausea, vomiting and a low white blood cell count. E-mail this page to a friend or colleague! To print, use this version